We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

PACS Company Honored by Award

By HospiMedica staff writers
Posted on 09 Nov 2005
Heartlab (Westerly, RI, USA), an Agfa (Mortsel, Belgium) company, recently announced a 2005 Business Development Leadership Award from Frost & Sullivan (Palo Alto, CA, USA), the international growth consultancy company.

The award recognizes Heartlab's ability to perceive and meet consumer needs by successfully developing and introducing products and services and by identifying new market segments to expand the existing customer base.

"In the intensely competitive U.S. cardiology PACS [picture archiving and communication systems] environment, Heartlab has consistently anticipated and met the needs of the marketplace,” said Katherine Shariq, senior industry analyst at Frost & Sullivan. "Heartlab's rigorous and ongoing analysis of customer needs and its continuous development and adoption of state-of-the-art analytics, network, storage, and IS [information system] integration solutions enables it to meet the future needs of its expanding customer base.”

Moreover, Frost & Sullivan's 2005 survey of the U.S. cardiology (PACS) market showed Heartlab as the third largest provider of cardiology PACS solutions in the United States in 2004. With 17.8% for direct sales and 2.5% for indirect original equipment manufacturer (OEM) sales (through its parent company, Agfa), Heartlab has increased its share of the US$166 million U.S. market by more than 8% from 2002, the last year that Frost & Sullivan surveyed the market.

"As the market continues to evolve, Heartlab has emerged as the only viable modality independent solution provider for Cardiology information systems,” said Robert Petrocelli, Heartlab's CEO.





Related Links:
Agfa
Frost & Sullivan

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Vertebral Body Replacement System
Hydrolift
New
Diagnosis Display System
C1216W

Latest Business News

Boston Scientific Acquires Medical Device Company Intera Oncology

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024